2981 - 2990 of 4301 Drugs

Lagevrio (molnupiravir)

Lagevrio (molnupiravir) is an investigational nucleoside analogue medicine used to treat mild-to-moderate COVID-19 in adults with positive results of direct SARS-CoV-2 viral testing, and who are at risk for progression to severe COVID-19 including hospitalization or death, and for whom other COVID-19 treatment options approved or authorized by the FDA are not accessible or clinically appropriate.

Lamictal (lamotrigine)

Lamictal (lamotrigine) is an anticonvulsant used alone or in combination with other antiseizure medications for treating certain types of seizures. Lamictal is available as a generic drug.

Lamictal XR (lamotrigine extended-release tablets)

Lamictal XR (lamotrigine) is an anti-epileptic drug used alone or in combination with other medications to treat seizures in adults and children who are at least 2 years old. Lamictal XR is also used to delay mood episodes in adults with bipolar disorder.

Lamisil (terbinafine)

Lamisil (terbinafine hydrochloride) is an antifungal antibiotic used to treat infections caused by fungus that affect the fingernails or toenails (onychomycosis). Oral granules are used to treat a fungal infection of scalp hair follicles in children who are at least 4 years old. Lamisil is available in generic form.

Temixys (lamivudine and tenofovir disoproxil fumarate tablets)

Temixys (lamivudine and tenofovir disoproxil fumarate) is a combination of two nucleoside reverse transcriptase inhibitors indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg.

Lampit (nifurtimox tablets)

Lampit (nifurtimox) is a nitrofuran antiprotozoal, indicated in pediatric patients (birth to less than 18 years of age and weighing at least 2.5 kg) for the treatment of Chagas disease (American Trypanosomiasis), caused by Trypanosoma cruzi.

Lamzede (velmanase alfa-tycv for injection)

Lamzede (velmanase alfa-tycv) is recombinant human lysosomal alpha-mannosidase indicated for the treatment of non-central nervous system manifestations of alpha-mannosidosis in adult and pediatric patients.

Takhzyro (lanadelumab-flyo injection)

Takhzyro (lanadelumab-flyo) is a plasma kallikrein inhibitor (monoclonal antibody) indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients 12 years and older.

Somatuline Depot (lanreotide)

Somatuline Depot (lanreotide) is an injection of a synthetic octapeptide used for the long-term treatment of acromegaly in patients who do not respond to, or cannot opt for, surgery or radiotherapy. The goal of treatment with acromegaly is to reduce growth hormone levels to normal.


Users in supermaster role can add new drug entries